Earnings
TARO
75.64
+1.60%
1.19
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-03-31
644.77M
644.77M
245.04M
399.73M
93.41M
59.78M
--
--
--
398.23M
--
246.53M
48.48M
--
3.02M
--
298.04M
53.48M
244.55M
-309.00K
244.24M
244.24M
0.00
--
6.35
FY 2019-03-31
669.89M
669.89M
224.17M
445.72M
89.97M
63.24M
--
--
--
373.70M
--
296.19M
58.85M
--
1.81M
--
356.85M
74.73M
282.12M
-345.00K
281.78M
281.78M
0.00
--
7.23
FY 2018-03-31
661.91M
661.91M
198.41M
463.51M
88.20M
70.42M
--
--
--
358.90M
--
303.01M
-12.53M
--
1.89M
--
292.37M
81.92M
210.45M
1.07M
211.52M
211.52M
-373.00K
--
5.27
FY 2017-03-31
879.39M
879.39M
207.86M
671.53M
85.66M
70.64M
--
--
--
364.44M
--
514.95M
34.64M
--
11.21M
--
560.80M
103.78M
457.02M
-310.00K
456.71M
456.71M
-352.00K
--
11.06
FY 2016-03-31
950.75M
950.75M
169.74M
781.01M
92.36M
71.16M
--
--
--
336.28M
--
614.47M
19.67M
--
2.68M
--
636.82M
95.31M
541.51M
-339.00K
541.17M
541.17M
-236.00K
--
12.63

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out TARO latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Taro Pharm recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.